Skip to main content

Table 3 Comparison between pre-treatment SUV, post-treatment SUV, and % change in SUV (∆SUV) of the responder and non-responder groups

From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

  Responder group Non-responder P-value
Pre-treatment SUV
 Median 14.6 10.9  
 IQR 11.8–17.7 4.95–20.7 0.396
 Range 10–20 3.5–34.7  
Post-treatment SUV
 Median 5.6 11.8  
 IQR 2.8–6.3 6.3–19.4 0.014
 Range 0–8 2–28.2  
∆SUV
 Median −63.1 −14.0  
 IQR −83.1 to −53.4 −32.8 to 54.9 0.0004
 Range −100 to −48.3 −54 to 113.5